SRSurendra Reddy
Twenty-five years asking one question: what should a system be allowed to do?

What institutional function should decide where AI capital goes, how much authority machines are permitted to hold, and which capabilities should compound across a private-equity portfolio?

The missing layer is not another AI centre of excellence. It is an allocation function.

Private equity has largely settled the question of AI adoption and has not settled the question of AI realisation. Sponsors increasingly have models, pilots, vendors, operating partners, and portfolio AI strategies. What they still lack is a disciplined institutional mechanism for allocating AI capital, governing delegated machine authority, proving realised value, and carrying what works from one holding to the next.

Musewoods Press · Strategy

The Compounding AI Program Office Capital Allocation · Delegated Authority · Portfolio Compounding

AI activity is no longer scarce. The scarce institutional capability is deciding where AI capital should go, what machines are permitted to change, what evidence proves the investment worked, and which capabilities should survive long enough to compound across the portfolio.

The design borrows an institutional principle from Berkshire Hathaway rather than an investment model: centralise the scarce judgment, decentralise operations, protect against permanent loss, learn from postmortems, and redeploy what works.

Enter the argument

00

Executive frame

The portfolio does not need more AI activity. It needs a way to allocate scarce AI capital and machine authority.

The AI Program Office is the sponsor-level institution that underwrites, allocates, governs, proves, transfers, and compounds.

The Argument in Five Moves

The paper can be understood as five connected claims.

  1. 01

    Adoption is no longer the constraint.

    Sponsors are funding pilots, appointing AI leaders, negotiating model access, and encouraging portfolio companies to move. Activity is real; realised enterprise value remains uneven.

  2. 02

    Capital allocation is the missing institutional function.

    The sponsor has mature machinery for allocating equity capital and far less discipline for deciding which AI opportunities deserve investment, at what scale, against which economic thesis, and with which kill criteria.

  3. 03

    Authority becomes capital when machines can act.

    A system that can change price, release code, approve a transaction, or contact a customer is exercising delegated authority. Permission must therefore be allocated, evidenced, bounded, observable, and revocable.

  4. 04

    Portfolio compounding depends on realised transfer.

    The first deployment is valuable locally; the sponsor-level advantage appears only when architecture, evidence, controls, methods, and operating knowledge reduce the cost and risk of subsequent deployments.

  5. 05

    Evidence is the office's durable asset.

    The office earns its mandate by remembering what was underwritten, what was actually realised, what failed, what transferred, and which forms of authority proved safe enough to expand.

The AI Program Office is the sponsor's institutional mechanism for allocating AI capital, governing delegated machine authority, transferring proven capability across portfolio companies, and compounding AI-enabled enterprise value across successive holdings.

  • UNDERWRITE
  • ALLOCATE
  • DELEGATE
  • EXECUTE
  • OBSERVE
  • PROVE
  • TRANSFER
  • COMPOUND

01

The constraint

A private-equity firm knows how to allocate a dollar of equity. It rarely applies the same discipline to a dollar of AI spend.

The absence of an allocation function turns AI strategy into distributed enthusiasm, vendor influence, and uneven management attention.

A private equity firm has a highly developed apparatus for deciding where equity capital should go. Investment committees, underwriting standards, hurdle rates, hold-period models, downside cases, and exit theses exist because capital is scarce and mistakes compound. AI capital is being deployed with far less institutional discipline. Sponsors may fund multiple pilots, appoint AI leaders, negotiate portfolio-wide model agreements, and ask each company to write an AI strategy, yet the decision about which opportunity deserves material capital is often still made informally through operating-partner conviction, management enthusiasm, vendor relationships, and local urgency.

The asymmetry is difficult to defend. The same institution that would not commit two million dollars of equity without a written investment thesis can commit comparable AI spend across a portfolio without an explicit baseline, economic mechanism, authority model, attribution method, transfer thesis, or pre-agreed condition for stopping. The problem is not lack of activity. It is lack of allocation discipline.

Capital allocation without an authority model produces fast adoption and unbounded downside. Authority governance without capital allocation produces a compliance function that slows everything and improves nothing.

The AI Program Office exists to hold both problems at once. It treats AI capital as an investment portfolio rather than a technology budget, and it treats machine authority as a bounded institutional resource rather than as a capability implicitly granted when a system reaches production. The sponsor-level function is therefore neither a central implementation team nor a detached governance office. It is the place where economic judgment and delegated authority are made explicit before consequential work moves.

02

Evidence

Adoption is settled. Realisation is not.

The evidence supports building an allocation function, but it does not support pretending that one fixed AI playbook explains every source of value.

The broad enterprise picture is consistent. AI activity is widespread, innovation and efficiency are common objectives, and the earnings consequence remains concentrated. Across McKinsey's survey waves, fundamental workflow redesign has the strongest association with whether organisations report EBIT impact, yet only about a fifth of adopters had fundamentally redesigned a workflow at the time of measurement. The scarce input is therefore not simply model access. It is the willingness and institutional capacity to change how work is actually done.

The private-equity evidence points in the same direction. Boston Consulting Group observed in January 2026 that PE leaders believed strongly in AI's value-creation potential and were investing in technology and talent, while the sector's realised impact remained modest and few firms could demonstrate meaningful returns across many portfolio companies. BCG's distinction between deploy, reshape, and invent is useful because it separates licence distribution from operating-model redesign and from AI embedded directly into the product or business model.

AI creates enterprise value through at least two different mechanisms.

Earnings mechanism

Workflow and operating-model redesign change how the company works. The available evidence most strongly associates this mechanism with EBIT impact during the hold period.

Multiple mechanism

Embedding AI into products, services, or new businesses changes what the company sells. The available PE-specific evidence associates this mechanism with the larger valuation step.

The valuation inflection in McKinsey's 471-company PE-backed sample did not appear between opportunistic adoption and operating-model enhancement. It appeared when AI changed what the company sold. Set beside the workflow evidence, that produces a two-mechanism allocation view: operating-model work primarily buys earnings; product and business-model work may buy the exit multiple.

What the evidence will and will not carry

01

The PE-specific sample is useful and selected.

The 471-company study spans thirty countries and thirty-one industries, but only twenty-one companies sit at the highest AI maturity level.

The association between higher AI maturity and higher revenue multiples is real in the sample. The direction of causation is not recoverable, especially because younger, software-weighted, AI-native businesses may both describe themselves differently and trade differently.

What claim survives the selection effect?

02

Autonomous deployment remains early.

Agent deployment remains in the low single digits across most business functions.

The authority problem is strategically important before it is broadly measured. That is a reason to build the architecture early, not a reason to overstate current autonomous adoption.

How much can any portfolio credibly claim about autonomous execution today?

03

Popular failure statistics are not underwriting evidence.

The widely circulated claim that ninety-five percent of AI pilots fail derives from a preliminary, non-peer-reviewed report with publicly contested methodology.

The office needs a stronger evidentiary standard than the market's rhetoric. A memorable statistic is not a substitute for a source that can carry the claim being made.

What should an investment memorandum refuse to repeat?

TAKEAWAY ON EVIDENCE

The evidence is strong enough to justify building an allocation function and too thin to justify a fixed playbook. That asymmetry is itself an argument for an office whose primary output is evidence.

03

Competitive reality

The centralised portfolio AI function already exists. The surviving gap is narrower and more defensible.

Portfolio compounding is now consensus. Authority allocation, evidentiary discipline, transfer option pricing, and structural independence are not.

The market no longer permits a claim that private equity lacks centralised AI capability. EQT's Motherbrain spans the investment lifecycle and has extended into portfolio-facing advisory work. KKR's Capstone model integrates operating capability with deal teams. Vista embeds engineers, operators, and AI specialists inside portfolio businesses. Google Cloud has reached portfolio-wide arrangements with multiple sponsors, and Blackstone and Hellman & Friedman formed Ode with Anthropic in 2026. EY reporting indicates that roughly four in five US private-equity firms have appointed a chief AI officer.

The portfolio-transfer argument is equally public. BCG recommends piloting repeatable playbooks and translating them across holdings. McKinsey describes the PE firm's role as expanding from asset selection toward repeatable AI-enabled initiatives that can create value across the fund and become reusable in future investments. Portfolio compounding is therefore not the discovery. It is the starting assumption.

Four Conventional Answers

Each common construct solves a real problem and fails as the sponsor's allocation function.

Construct
Strength
Structural Failure

AI centre of excellence

Strength

Expertise and standards

Structural Failure

Holds no capital and therefore no leverage over which initiatives actually receive investment.

Transformation programme

Strength

Implementation and change

Structural Failure

Learning is bounded to the project or company and often disappears when the engagement ends.

Shared services

Strength

Common capability and cost efficiency

Structural Failure

Optimises for what is easy to standardise rather than what carries the greatest enterprise value.

External consulting

Strength

Expertise and execution capacity

Structural Failure

Accumulated judgment leaves when the team does, and incentives may favour implementation volume over stopping.

Surviving Gap

Four commitments remain structurally under-supplied.

  1. 01

    Allocate authority as well as capital.

    Decide what machines may change, on whose identity they act, what evidence supports autonomy, and what revokes permission.

  2. 02

    Hold realised value to an evidentiary standard.

    Capture baselines before deployment, record attribution methods, and compare realised outcomes with the thesis that justified the spend.

  3. 03

    Price transfer option value into the original underwriting.

    The expected reuse count should be named before the first deployment and tested after the first year.

  4. 04

    Remain independent of the model and implementation layers.

    The party deciding whether a programme should expand, stop, or change vendors should not earn more when implementation volume increases.

04

The thesis

The AI Program Office is an allocation institution, not an AI delivery organisation.

Its product is an allocation decision supported by evidence. Its asset is the accumulating record of which decisions were right.

The AI Program Office is the sponsor's institutional mechanism for allocating AI capital, governing delegated machine authority, transferring proven capability, and compounding AI-enabled enterprise value across successive holdings.

Maximum risk-adjusted enterprise value per unit of AI capital and per unit of machine authority.

The office underwrites opportunities, allocates scarce shared capability, defines authority boundaries, measures realised economics, captures reusable assets, and transfers what works. It does not optimise for number of pilots, licences, agents, or initiatives in flight.

Not a centre of excellence. Not an internal consultancy. Not a central implementation factory.

The operating companies remain responsible for their business problems, workflows, management decisions, implementation choices, adoption, and P&L outcomes. The office centralises the judgment and the non-negotiable boundaries that benefit from portfolio scale while leaving operating responsibility where the context actually lives.

05

Institutional architecture

Berkshire supplies an architecture for disciplined decentralisation, not a template for private-equity ownership.

The useful translation is a small centre governing a large collection of autonomous businesses through allocation discipline, hard boundaries, postmortems, resilience, and redeployment.

Berkshire Hathaway is not a model for private equity. Its ownership horizon, capital structure, and acquisition philosophy differ materially from those of a buyout fund. The useful borrowing is institutional: centralise the scarce judgment, decentralise operations, preserve hard controls, learn from mistakes, and redeploy what one business generates into another.

Six Berkshire translations

What changes when Buffett's institutional logic is applied to portfolio AI?

The analogy is valuable where it disciplines allocation and dangerous where it hides the differences between permanent ownership and a finite hold.

Principle

01

Centralise allocation, decentralise operation

A fund-level office that tries to run AI inside every portfolio company becomes slow and context-poor; a fund that delegates everything gets incompatible systems and no institutional learning.

Operating questionWhat belongs at sponsor level, and what must stay inside the operating company?

The office should establish investment doctrine, underwrite material opportunities, allocate scarce shared capability, set architecture and authority boundaries, maintain a common evidence standard, codify reusable assets, and measure portfolio economics. The portfolio company should define the business problem, own the operating outcome, execute the change, adapt to local systems, produce evidence, and deliver the P&L result. Centralise judgment and non-negotiable boundaries; decentralise operating decisions and accountability.

THE ABCs OF AI DECAY

Evidence against arrogance. Enforceable delegation against bureaucracy. Continuous re-underwriting against complacency.

Arrogance assumes model capability implies production reliability. Bureaucracy turns governance into committees and approval queues rather than executable boundaries. Complacency mistakes procurement or a published AI strategy for transformation. The office needs institutional habits that push against all three.

06

Operating model

The centre stays small because its leverage comes from judgment, evidence, architecture, and reuse.

The office manages five forms of capital through four institutional systems and one explicit authority architecture.

Five Forms of AI Capital

Budget is only one scarce resource.

Capital
Scarcity
Allocation Question

Financial

Scarcity

Investment budget

Allocation Question

Where does the next dollar create the greatest risk-adjusted value?

Technical

Scarcity

Architects · engineers · infrastructure

Allocation Question

Where should scarce implementation capability be deployed?

Data

Scarcity

Proprietary information and access

Allocation Question

Which data assets warrant integration, protection, or productisation?

Management

Scarcity

Executive attention

Allocation Question

Which initiatives deserve CEO, board, and operating-partner attention?

Authority

Scarcity

Permission for machines to act

Allocation Question

Where can autonomy safely expand, and where must it remain constrained?

Treating authority as capital has a practical consequence: the office maintains a register of how much machine authority is outstanding across the portfolio, which systems hold it, what evidence earned it, and what conditions would cause it to be withdrawn. Compute can be purchased. Trusted authority has to be earned and maintained.

Four institutional systems

The office converts opportunity into evidence and evidence into reusable portfolio capability.

Each system exists because the previous one cannot safely answer the next question by itself.

System

01

AI Underwriting

A rapid assessment is an entry mechanism; the durable output is an AI Investment Memorandum.

Operating questionWhat must be true before the sponsor should invest?

Each memorandum states the business problem and baseline economics, the proposed intervention, expected operating change, capital required, implementation risk, authority level requested, expected economic outcome, evidence required before scaling, transferability to other companies, and the conditions under which the initiative should be terminated. Kill criteria are written before capital is committed because criteria written after a programme has a champion are not credible kill criteria.

Authority Envelope

Every material capability carries an explicit delegation boundary.

Dimension
Operating Question

Scope

Operating Question

What may the system decide or change?

Identity

Operating Question

On whose authority does it act?

Evidence

Operating Question

What information must support the action?

Threshold

Operating Question

When may it act autonomously?

Escalation

Operating Question

What requires a human decision?

Observability

Operating Question

What evidence must be retained?

Reversibility

Operating Question

Can the action be undone?

Accountability

Operating Question

Who owns the resulting outcome?

Runtime architecture

Governance must travel with the system rather than live in a committee calendar.

Decision, enforcement, evidence, competency, and accountable action should remain distinguishable.

In the 451 architecture, Pola is the policy decision point and decides. The Governor is the policy enforcement point and enforces while holding no write path of its own. Actra is the governed event stream that preserves accountable action history. Hubli supplies the competency and promotion surface and holds no decision or enforcement power. The separation matters because a governance layer that can also act is not a governance layer.

07

Economic architecture

The office needs a ledger that remembers the thesis, not a dashboard that celebrates the activity.

Realised value, transfer economics, authority exposure, and strategic optionality have to be visible in one operating view.

AI Intrinsic Value Ledger

A portfolio-wide ledger compares AI investment hypotheses with economic reality.

Dimension
What It Measures

Capital committed

What It Measures

Cash, people, infrastructure, and management attention

Underwritten value

What It Measures

Expected annual or exit-period economic contribution

Realised value

What It Measures

Verified economic benefit achieved

Time to value

What It Measures

Duration from commitment to measurable result

Confidence

What It Measures

Quality of the supporting evidence

Risk exposure

What It Measures

Downside created or mitigated

Reusability

What It Measures

Applicability elsewhere in the portfolio

Marginal replication cost

What It Measures

Cost of the next deployment

Authority level

What It Measures

Consequence of autonomous action

Strategic optionality

What It Measures

New products, markets, data, or business models enabled

Every portfolio company will generate more plausible AI opportunities than the fund can economically pursue, so scarcity should be made explicit rather than diffused. Initiatives compete on enterprise-value potential, probability of success, time to value, strategic importance, transferability, and risk. The ranking should be visible rather than negotiated privately, and the resulting allocation should be asymmetric by design.

Some companies should receive materially more AI capital than others. Some need defensive modernisation only. A smaller number warrant operating-model transformation, and fewer still justify AI-native product development or business creation. Equal-budget allocation and a rule that every company needs an AI strategy are symptoms of a sponsor that has not created an allocation function.

Let the first deployment cost C and return annual benefit B. Let r be the share of first-deployment cost eliminated on subsequent deployments through captured architecture and operating knowledge, and let k be the share of the original benefit a subsequent deployment achieves. With C at $600,000, B at $1.5 million, r at 0.71, and k at 0.5, subsequent deployments cost $175,000 and return $750,000 annually.

DeploymentsPortfolio costAnnual benefitBenefit to costCapital saved versus building fresh
1$600,000$1,500,0002.500
2$775,000$2,250,0002.90$425,000
3$950,000$3,000,0003.16$850,000
5$1,300,000$4,500,0003.46$1,700,000
8$1,825,000$6,750,0003.70$2,975,000

Two sensitivities determine whether the compounder thesis holds. Reuse capture drives marginal economics directly, and realised reuse count determines how much of the claimed portfolio value exists at all. Under the illustrative assumptions above, a transfer needs only $437,500 of annual benefit to clear a 2.5x first-year hurdle. The binding constraint is therefore not whether a successful transfer can pay. It is whether the organisation actually transfers.

The first deployment should consequently be underwritten as the purchase of a capability plus an option on a named set of subsequent deployments at reduced marginal cost. The expected reuse count belongs in the original memorandum, should be associated with specific candidate companies, and should be tested at the twelve-month review. An option nobody has priced is an option nobody is accountable for exercising.

Every material initiative should declare which economic mechanism it is buying.

Earnings mechanism

Redesign workflows and operating models when the hold period and business condition favour EBITDA, margin, productivity, or operating improvement.

Multiple mechanism

Embed AI into products, services, or new businesses when the company has enough time and strategic position for the market to value a changed proposition.

ALLOCATION RULE

Productivity tooling that changes neither operating economics nor what the company sells is a hygiene cost. Procure it; do not pretend it is an investment thesis.

08

Deployment

Do not begin by building an organisation. Begin by building the allocation discipline.

The first year should prove that the office can find value, stop weak investments, codify what works, and make deployment N+1 measurably better because deployment N occurred.

Days 0–60

Establish portfolio truth

Rapid underwriting runs across selected companies, the ledger is stood up, and existing initiatives, vendor commitments, capabilities, risks, and economic hypotheses are inventoried. The objective is three answers: where value is available, where capital is being wasted, and where AI could threaten a current underwriting assumption.

Days 60–120

Build the allocation engine

The office establishes the investment memorandum, authority classification, economic scorecard, kill criteria, and portfolio review cadence. A small number of initiatives are selected to generate evidence rather than maximise activity.

Months 4–8

Prove and codify

Selected initiatives execute, realised economics are measured against the memorandum, and reusable architecture, implementation patterns, evaluation assets, and governance mechanisms are captured. Candidate compounders must become visible here.

Months 7–12

Transfer and scale

The office deliberately moves proven capability across holdings and measures whether deployment N+1 is cheaper, faster, and more reliable because deployment N occurred. This is where the office earns or loses its sponsor mandate.

Executive Scorecard

Keep the scorecard short enough that it can change allocation decisions.

  1. 01

    Economics

    Verified value created per unit of AI capital, annualised EBITDA or revenue impact, and enterprise-value contribution.

  2. 02

    Execution

    Median time from underwriting to verified value, share killed before major commitment, and share meeting the original economic thesis.

  3. 03

    Compounding

    Reuse count per codified capability, marginal cost reduction, time reduction, and number of validated compounders.

  4. 04

    Governance

    Share of material systems carrying explicit authority envelopes, evidence completeness, and material incidents measured against authority outstanding rather than system count.

Portfolio AI leader

Strategy and allocation

AI value architect

Connects investment theses to operating economics

Enterprise architect

Defines reusable technical foundations and interoperability

Governance architect

Defines authority, evidence, policy, and assurance

Transformation lead

Connects the office to CEOs, operating partners, and implementation teams

Specialist implementation capacity should come from portfolio teams, external partners, or a governed engineering bench. The office should resist becoming a permanent delivery organisation because its leverage comes from judgment, architecture, accumulated knowledge, and reuse; a delivery organisation's incentives naturally pull toward volume.

A mature office affects the full investment lifecycle. Underwriting improves because the fund develops a proprietary view of which businesses are genuinely advantaged or threatened by AI. Time from acquisition to economic intervention shortens because common architecture, evidence standards, and operating patterns already exist. Portfolio economics improve because shared learning lowers the marginal cost and execution risk of transformation.

Exits can improve because the sponsor can present evidence of AI-enabled operating change and proprietary capability rather than a generic claim that a company is AI-enabled. Management teams gain access to capabilities they could rarely justify alone, which strengthens the acquisition proposition. Limited partners gain evidence that the fund has developed a repeatable operating capability rather than relying only on deal selection and leverage. The last of these is also the simplest to test: a fund that cannot show the ledger has not built the capability.

09

Differentiation

Prior art comes first. The differentiation is credible only after the concessions.

Portfolio compounding, central capability, investment-thesis alignment, and reusable playbooks are already in the market and are not claimed as novel.

Beginning with evidence rather than a transformation hypothesis is standard practice among credible entrants. Connecting AI to the investment thesis is the explicit position of major strategy and private-equity advisory firms. Centralising fund-level capability and transferring playbooks between holdings is published advice and installed practice. Well-capitalised implementation ventures will also build reusable intellectual capital faster than a small advisory organisation can. None of those positions is a defensible differentiation basis.

What survives contact with the landscape

Four commitments remain coherent together.

Allocate authority, not only capital

Maintain an authority register, issue explicit envelopes, separate decision from enforcement, and widen permission only against accumulated competency evidence.

Remain structurally independent

Hold no revenue relationship with a model provider, cloud provider, or implementation venture when advising the sponsor on whether to expand, replace, redesign, or stop.

Hold realised value to evidence

Capture baselines before deployment, record attribution methods, and distinguish what was measured from what was reported.

Price transfer option value

Name expected reuse count, assign candidate companies, and test the option at review because the portfolio return depends on realised transfer rather than on rhetoric about reuse.

POSITIONING VERDICT

Proceed with these four commitments as the differentiation basis. Stop any claim that portfolio compounding itself is novel; that belongs to the published market record.

Constraints the model must survive

01

Cross-portfolio transfer is legally constrained.

Operating knowledge, benchmarks, pricing capability, and data models may carry confidentiality, co-investor, competition, and antitrust obligations.

The office needs counsel-approved transfer classes. Generic architecture, methods, evaluation patterns, and governance artefacts may travel more freely than commercially sensitive operating knowledge, pricing, customer information, or data.

What may travel safely between holdings?

02

Capability leaves at exit.

The deployed instance belongs to the company that will eventually be sold.

Codification cannot be a post-project courtesy. Fund-level artefacts should be produced as a condition of funding and designed to survive the sale of the operating company.

What must the sponsor capture before exit?

03

The evidence base is thinner than the market's confidence.

The strongest PE-specific dataset is associative, selected, and small at the highest maturity level.

The ledger is partly a value-management system and partly a mechanism for generating the causal evidence the field does not yet possess. The office should make uncertainty visible rather than hide it behind industry confidence.

What should the office do with uncertainty?

04

Internal ownership is a live alternative.

Many sponsors have already appointed chief AI officers and may reasonably decide that the function belongs inside.

If structural independence, allocation discipline, and evidence are not valued as distinct capabilities, the correct response is not to reposition as staff augmentation. It is to decline.

When should an external office decline the engagement?

10

Falsification

A standing thesis should name the evidence that would force it to change.

The model is useful only if it can fail.

Falsifiers

Five conditions would materially weaken or overturn the thesis.

  1. 01

    Reuse does not happen.

    If realised reuse count across codified capabilities stays below two after twelve months of deliberate transfer effort, portfolio compounding is arithmetic without a referent.

  2. 02

    Authority governance is not a purchased capability.

    If sponsors treat authority envelopes as compliance paperwork rather than an allocation instrument, the differentiated governance layer collapses into documentation.

  3. 03

    The multiple mechanism is pure selection.

    If stronger controlled studies show that AI-native founding characteristics rather than purchasable AI capability explain the valuation steps, the allocation rule reduces to the earnings mechanism alone.

  4. 04

    Implementation ventures build genuine authority governance.

    If the large implementation providers create credible independent mechanisms for allocating and constraining machine authority, this position loses one of its central structural advantages.

  5. 05

    Portfolio companies will not fund the recurring capability.

    If the model depends entirely on sponsor-level budget, its economics and organisational design change materially.

Berkshire's advantage was never that headquarters ran each operating company better than its own management. The advantage came from disciplined selection, rational allocation, deep delegation, protection against permanent loss, learning from mistakes, resource redeployment, and the ability to let advantages generated in one business create opportunity elsewhere.

Private equity has a parallel opportunity, but the opportunity is no longer the generic idea of portfolio AI. What remains structurally useful is the harder half: an allocation function that treats machine authority as capital, holds realised value to an evidentiary standard, prices transfer option value into the original underwriting, and remains independent of the parties selling the implementation.

Underwrite before investing. Allocate rather than distribute. Delegate within enforceable boundaries. Measure intrinsic value rather than activity. Transfer what works within the limits counsel permits. Learn from what does not. Protect against permanent loss. Compound only what survives the exit.

A conventional AI programme asks where AI can be used. A transformation programme asks where AI can improve this business. The Compounding AI Program Office asks where AI capital and machine authority should be allocated today so that the value of this company rises while the capability of the portfolio rises with it.

Appendix

Evidence base and limits

Every material empirical claim should remain attached to what supports it and what it cannot prove.

#ClaimSource and standing
139 percent of organisations report any enterprise EBIT impact from AI; roughly 6 percent qualify as AI high performersMcKinsey State of AI global survey 2026, 1,719 respondents. Primary source. One secondary report renders the first figure as 37 percent; the primary is used here.
2Fundamental workflow redesign has the strongest association with EBIT impact; about 21 percent of adopters had attempted itMcKinsey State of AI, March 2025 wave, tested against roughly 25 organisational attributes. Association, measured across a general enterprise sample rather than a PE sample.
3Few PE firms could show meaningful AI returns across portfolio companies in 2025; deploy, reshape, invent frameworkEmerson, O'Niell, and Kapadia, BCG, 23 January 2026. Practitioner observation supported by BCG's transformation base rather than a published instrument.
4471 PE-backed companies classified into four AI capability levelsPulido, Yegoryan, Bleys, and Haas, McKinsey, 23 June 2026.
5Level four median revenue multiple of 31x; broad adopters roughly 130 percent above opportunistic; revenue per employee $180,000 at level four against $118,000 at level threeSame source. Sample restricted to 2023-onward deals, revenue $1M to $250M, multiples 5x to 300x, 30 countries, 31 industries, median founding year 2015, with 21 companies at level four. Association, not causation.
6Level one and level two median multiples are 13x and 14x, with the inflection at level threeSame source. This is the basis of the two-mechanism allocation rule.
7Agent deployment remains in the low single digits across most business functionsStanford HAI AI Index 2026. Constrains claims about autonomous execution at portfolio scale.
8Roughly four in five US private-equity firms have appointed a chief AI officerAttributed to EY and reached through secondary reporting. Directional pending the primary instrument.
9Landscape positions: EQT Motherbrain and Motherbrain Labs, KKR Capstone, Vista's embedded model, Google Cloud portfolio agreements, and the Ode ventureCompany disclosures and trade reporting, 2024 to 2026.
10Compounder parameters: $600,000 first deployment, $1.5 million annual benefit, 0.71 reuse capture, 0.5 benefit ratioAssumptions, not findings. The model exposes sensitivity so sponsors can substitute their own parameters.
11The claim that ninety-five percent of AI pilots failNot used. It derives from a preliminary, non-peer-reviewed report with publicly contested methodology.

Sources

References

Sources supporting the empirical and institutional argument.

  1. Berkshire: Past, present and future

    Buffett, W. E. · 2015 · Special letter in Berkshire Hathaway Inc. 2014 annual report

  2. Private equity: Clearer view, tougher terrain

    Edlich, A., Llewellyn, C., Croke, C., Schneider, R., & Teichner, W. · McKinsey & Company · 2026

  3. The AI-first private equity firm

    Emerson, G., O'Niell, C., & Kapadia, T. · Boston Consulting Group · 23 January 2026

  4. The state of AI: How organizations are rewiring to capture value

    McKinsey & Company · QuantumBlack · 2025

  5. The state of AI: Global survey 2026

    McKinsey & Company · QuantumBlack · 2026

  6. Beyond productivity: How AI creates value in private equity

    Pulido, A., Yegoryan, H., Bleys, J., & Haas, S. · McKinsey & Company · 23 June 2026

  7. ADAM: A governed operating machine for AI-native software and multi-agent systems

    Reddy, S. · SSRN · 2026

  8. The ADAM Earned Authority Kernel

    Reddy, S. · SSRN · 2026

  9. Earned authority: Agent competency intelligence and the Agent Earned Authority Score

    Reddy, S. · SSRN · 2026

  10. The 2026 AI Index Report

    Stanford Institute for Human-Centered Artificial Intelligence · Stanford University · 2026

Continue the inquiry

The AI Program Office sits inside a larger institutional question.

Consequential intelligence requires context, authority, evidence, and accountability to become part of the operating system.

The AI Program Office sits inside a larger Musewoods inquiry about what happens when intelligence becomes capable of consequential action and institutions must make context, authority, evidence, and accountability part of the operating system.

The Compounding AI Program Office | Musewoods Press